Latest News for: vector cell
Edit
Future Trends in The Cell and Gene Therapy Market: Forecast Until 2035
Pharmiweb 04 Apr 2025
Cell And Gene Therapy Market Size and Forecast ... Innovations in gene editing, vector development, and personalized medicine are distinctly shaping the future of therapy products within the cell and gene therapy market ... Cell and Gene Therapy Market.
Edit
eXmoor Pharma Strengthens Board with Appointment of Dr James Miskin as Non-Executive Director
Pharmiweb 01 Apr 2025
It’s an exciting time for the cell and gene therapy sector, and eXmoor has a key role to play." ... eXmoor’s advanced therapies facility in Bristol, UK, supports Viral Vectors, Autologous and Allogeneic Cell Therapies, and RNA Technologies.
Edit
Correcting the Mutation Behind a Genetic Eye Disease
The Scientist 27 Mar 2025
This eventually leads to the accumulation of toxic forms of vitamin A, causing retinal cell death. As these cells die, people gradually lose the ability to read, drive, and recognize faces ... Cell & Gene Therapy.
Edit
Nouscom to Present Final Results from Successful Phase Ib/II Trial of NOUS-209 in People Living with Lynch Syndrome, Demonstrating Powerful Potential to Intercept Cancer in its Earliest Stages of Development
Pharmiweb 26 Mar 2025
NOUS-209 is comprised of two proprietary viral vectors able to deliver 209 shared FSP neoantigens and train the immune system to recognize and attack cancerous and pre-cancerous cells before tumors can develop.
Edit
Non-Hodgkin’s Lymphoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, ...
GetNews 25 Mar 2025
Edit
Adeno-Associated Virus (AAV) Vectors in Gene Therapy Clinical Trials and Studies 2025: EMA, PDMA, FDA ...
GetNews 24 Mar 2025
Discover the latest drugs and treatment options in the Adeno-Associated Virus (AAV) Vectors in Gene Therapy Pipeline ... Stay ahead with the most recent pipeline outlook for Adeno-Associated Virus (AAV) Vectors in Gene Therapy.
Edit
B-Cell Lymphoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, ...
GetNews 24 Mar 2025
Edit
Bharat Biotech launches India's only integrated cell, gene therapy, and viral production facility
Beijing News 20 Mar 2025
The facility is equipped for advanced viral vector production, designed to produce high-titer viral vectors such as AAV, Lentivirus, and Adenovirus, which are essential for cell and gene therapy applications.
Edit
Bharat Biotech sets up $75 million integrated Cell and Gene Therapy, viral production facility in Hyderabad
Business Line 20 Mar 2025
... & Viral Vector Production facility in Genome Valley here with an investment of $75 million.
- 1